Table 3 Estimation of preferences from the mixed logit model
Attributes | β coefficients | RI | ||
|---|---|---|---|---|
Mean (SE) | SD (SE) | |||
HbA1c control | 16.24 | |||
Not as expected (ref) | -0.724***(0.073) | |||
As expected | 0.724***(0.073) | 0.825***(0.102) | ||
Serious side effects | 7.39 | |||
Sometimes (ref) | -0.377***(0.072) | |||
Occasionally | 0.096 (0.061) | -0.031 (0.135) | ||
Never or rarely | 0.281***(0.061) | -0.235 (0.208) | ||
Length of extended life | 26.48 | |||
Extended life (per year) | 0.787***(0.074) | 0.991***(0.091) | ||
Change in HRQoL | 34.25 | |||
Worse (ref) | -1.670***(0.124) | |||
No improvement | 0.287***(0.070) | -0.432**(0.138) | ||
Improvement | 1.383***(0.110) | 1.121***(0.109) | ||
Dosing frequency | 3.27 | |||
Twice a day (ref) | -0.132*(0.056) | |||
Once every other day | -0.028 (0.060) | 0.423***(0.101) | ||
Once a week | 0.160**(0.061) | -0.202 (0.183) | ||
Out-of-pocket costs per month | 12.38 | |||
Cost (per CNY50) | -0.138*** (0.021) | 0.327*** (0.030) | ||
Log likelihood | -2600.171 | |||
Participants | 639 | |||
Observations | 10,224 | |||